Safety of iron milk proteinate as a novel ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Safety of iron milk proteinate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of iron from this source in the context of Directive 2002/46/EC
Auteur(s) :
Turck, Dominique [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Castenmiller, J. [Auteur]
European Food Safety Authority [EFSA]
De Henauw, S. [Auteur]
Hirsch-Ernst, K. I. [Auteur]
Maciuk, A. [Auteur]
Mangelsdorf, I. [Auteur]
Mcardle, H. J. [Auteur]
Naska, A. [Auteur]
Pelaez, C. [Auteur]
Pentieva, K. [Auteur]
Siani, A. [Auteur]
Thies, F. [Auteur]
Tsabouri, S. [Auteur]
Vinceti, M. [Auteur]
Cubadda, F. [Auteur]
Frenzel, T. [Auteur]
Heinonen, M. [Auteur]
Maradona, M. P. [Auteur]
Marchelli, R. [Auteur]
Neuhauser-Berthold, M. [Auteur]
Poulsen, M. [Auteur]
Schlatter, J. R. [Auteur]
Van Loveren, H. [Auteur]
Acker, R. [Auteur]
Knutsen, H. K. [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Castenmiller, J. [Auteur]
European Food Safety Authority [EFSA]
De Henauw, S. [Auteur]
Hirsch-Ernst, K. I. [Auteur]
Maciuk, A. [Auteur]
Mangelsdorf, I. [Auteur]
Mcardle, H. J. [Auteur]
Naska, A. [Auteur]
Pelaez, C. [Auteur]
Pentieva, K. [Auteur]
Siani, A. [Auteur]
Thies, F. [Auteur]
Tsabouri, S. [Auteur]
Vinceti, M. [Auteur]
Cubadda, F. [Auteur]
Frenzel, T. [Auteur]
Heinonen, M. [Auteur]
Maradona, M. P. [Auteur]
Marchelli, R. [Auteur]
Neuhauser-Berthold, M. [Auteur]
Poulsen, M. [Auteur]
Schlatter, J. R. [Auteur]
Van Loveren, H. [Auteur]
Acker, R. [Auteur]
Knutsen, H. K. [Auteur]
Titre de la revue :
EFSA Journal
Nom court de la revue :
EFSA J.
Numéro :
20
Pagination :
-
Date de publication :
2022-09-25
ISSN :
1831-4732
Mot(s)-clé(s) en anglais :
iron milk proteinate
novel food
nutrient source
iron
bioavailability
safety
novel food
nutrient source
iron
bioavailability
safety
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) ...
Lire la suite >Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of iron from this source inthe context of Directive 2002/46/EC. The NF is a complex of iron, casein and phosphate, which isproduced from iron salts (i.e. ferric chloride or ferric sulfate), sodium caseinate and potassiumorthophosphate. The NF is proposed by the applicant to be used as a source of iron, of which the NFcontains 2–4%. The applicant intends to market the NF as an ingredient in a number of foodcategories; in food supplements, in total diet replacement for weight control and in foods for specialmedical purposes. The Panel considers that, taking into account the composition of the NF and theproposed conditions of use, consumption of the NF is not nutritionally disadvantageous. The studiesprovided for ADME and bioavailability indicate that iron from the NF is bioavailable. Overall, theevidence indicates that upon ingestion the NF undergoes digestion into small peptides to yield iron-bound caseinophosphopeptides that are normal constituents of the human diet, and that the iron fromthe NF does not bypass the homeostatic control of iron as a nutrient. The Panel concludes that the NF,iron milk proteinate, is safe under the proposed conditions of use. The Panel also concludes that theNF is a source from which iron is bioavailable.Lire moins >
Lire la suite >Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of iron from this source inthe context of Directive 2002/46/EC. The NF is a complex of iron, casein and phosphate, which isproduced from iron salts (i.e. ferric chloride or ferric sulfate), sodium caseinate and potassiumorthophosphate. The NF is proposed by the applicant to be used as a source of iron, of which the NFcontains 2–4%. The applicant intends to market the NF as an ingredient in a number of foodcategories; in food supplements, in total diet replacement for weight control and in foods for specialmedical purposes. The Panel considers that, taking into account the composition of the NF and theproposed conditions of use, consumption of the NF is not nutritionally disadvantageous. The studiesprovided for ADME and bioavailability indicate that iron from the NF is bioavailable. Overall, theevidence indicates that upon ingestion the NF undergoes digestion into small peptides to yield iron-bound caseinophosphopeptides that are normal constituents of the human diet, and that the iron fromthe NF does not bypass the homeostatic control of iron as a nutrient. The Panel concludes that the NF,iron milk proteinate, is safe under the proposed conditions of use. The Panel also concludes that theNF is a source from which iron is bioavailable.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Date de dépôt :
2024-01-12T00:30:02Z
2024-03-08T14:55:45Z
2024-03-08T14:55:45Z
Fichiers
- EFSA Journal - 2022 - - Safety of iron milk proteinate as a novel food pursuant to Regulation EU 2015 2283 and.pdf
- Version éditeur
- Accès libre
- Accéder au document